Novel Non-Pharmacological Insomnia Treatment – a Pilot Study
Nature and Science of Sleep Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Novel non-pharmacological insomnia treatment – a pilot study This article was published in the following Dove Press journal: Nature and Science of Sleep Milena K Pavlova1 Objective: The objective of this prospective pilot study was to examine the effects of a Véronique Latreille1 novel non-pharmacological device (BioBoosti) on insomnia symptoms in adults. Nirajan Puri1 Methods: Subjects with chronic insomnia were instructed to hold the device in each hand Jami Johnsen1 for 8 mins for 6 cycles on a nightly basis for 2 weeks. Outcomes tested included standardized Salma Batool-Anwar2 subjective sleep measures assessing sleep quality, insomnia symptoms, and daytime sleepi- ness. Sleep was objectively quantified using electroencephalogram (EEG) before and after 2 Sogol Javaheri2 weeks of treatment with BioBoosti, and wrist actigraphy throughout the study. Paul G Mathew1 Results: Twenty adults (mean age: 45.6±17.1 y/o; range 18–74 y/o) were enrolled in the 1Department of Neurology, Harvard study. No significant side effects were noted by any of the subjects. After 2 weeks of Medical School, Brigham and Women’s BioBoosti use, subjects reported improved sleep quality (Pittsburgh Sleep Quality Index: Hospital, Boston, MA, USA; 2Department of Medicine, Harvard Medical School, 12.6±3.3 versus 8.5±3.7, p=0.001) and reduced insomnia symptoms (Insomnia Severity Brigham and Women’s Hospital, Boston, Index: 18.2±5.2 versus 12.8±7.0, p<0.001). Sleepiness, as assessed by a visual analog For personal use only.
[Show full text]